Moderna Inc Bdr (M1RN34) Stock Price & News

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia

About Moderna Inc Bdr

CEOStéphane Bancel

Employees4.7 мян

Founded9-р сар 2010

Headquarters-

SectorHealth Care

Industry-

Websitemodernatx.com

All values in USD	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	1.02 тэрбум	678.00 сая	389.00 сая	145.00 сая
Cost of goods sold	1.01 тэрбум	1.23 тэрбум	726.00 сая	738.00 сая
Cost of revenue	1.01 тэрбум	1.23 тэрбум	726.00 сая	738.00 сая
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	268.00 сая	308.00 сая	173.00 сая	216.00 сая
Operating expense	268.00 сая	308.00 сая	173.00 сая	216.00 сая
Total operating expenses	1.28 тэрбум	1.54 тэрбум	899.00 сая	954.00 сая
Operating income	-260.00 сая	-857.00 сая	-510.00 сая	-809.00 сая
Other non operating income	-4.00 сая	-2.00 сая	-	-2.00 сая
EBT including unusual items	-187.00 сая	-799.00 сая	-1.33 тэрбум	-767.00 сая
EBT excluding unusual items	-191.00 сая	-797.00 сая	-455.00 сая	-761.00 сая
Income tax expense	13.00 сая	27.00 сая	9.00 сая	15.00 сая
Effective tax rate	-6.95%	-3.38%	-0.67%	-1.96%
Other operating expenses	-	-	-	-
Net income	-200.00 сая	-826.00 сая	-1.34 тэрбум	-782.00 сая
Net profit margin	-19.68%	-121.83%	-345.24%	-539.31%
Earnings per share	-0.51	-2.11	-3.40	-1.97
Interest and investment income	73.00 сая	70.00 сая	72.00 сая	67.00 сая
Interest expense	-	-8.00 сая	-17.00 сая	-17.00 сая
Net interest expenses	73.00 сая	62.00 сая	55.00 сая	50.00 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	-208.00 сая	-790.00 сая	-451.00 сая	-746.00 сая
Gain or loss from assets sale	-	-	-	-

Ask anything